Back

Genotype-phenotype correlations in patients with titin variants and cardiomyopathy from a Swiss cohort

31 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Hypertrophic and other cardiomyopathies: miscellaneous findings Dilated Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Nina Schaetti

See-Spital Horgen, Horgen (Switzerland)

9 More presentations in this session

Presentation thumbnail
Sex-based differences in anatomical and hemodynamic parameters and outcomes in patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation
Doctor A. Damlin (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and burden of non-obstructive hypertrophic cardiomyopathy: a real-world survey in Italy and Spain
Miss M. Lowe (Macclesfield, GB)
Abstract Slides Video
Presentation thumbnail
Symptoms trend in patients with obstructive hypertrophic cardiomyopathy treated with disopyramide.
Doctor F. Borrelli (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: observations from a tertiary care center
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Amplicon-based long-read sequencing is useful for confirming zygosity of DSG2 variants associated with Japanese ARVC.
Doctor K. Sonoda (Suita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic and other cardiomyopathies: miscellaneous findings

The Event

Event poster

ESC Congress 2024

31 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of atrial and ventricular arrhythmias in patients with titin truncating variants across the ventricular morphofunctional phenotypic spectrum
thumbnail
Congress Presentation
Targeting titin in dilated cardiomyopathy
thumbnail
Congress Presentation
Insights on Titin cardiomyopathy: from truncating variants site to phenotypic expression and outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources